Research
Neural
Tirzepatide dose-dependently reduced voluntary alcohol consumption and prevented binge and relapse-like drinking.
Tirzepatide may help in managing alcohol use disorder by reducing consumption and preventing relapse.
StrongSupportsmedium confidence
Subsequently, this GLP-1R/GIPR agonist dose-dependently reduced voluntary alcohol consumption (P < 0.001), prevented binge (P < 0.01) and relapse-like drinking (P < 0.001).
Why this rating
Supported by multiple behavioral assays.
Source
Tirzepatide reduces alcohol drinking and relapse-like behaviours in rodents
Christian E. Edvardsson et al. · EBioMedicine · 2026
otherCited 5×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →